The types of @entity8 in the XXXX .

@entity1 @entity644 @entity8 @entity295 @entity63 @entity5507 @entity177 @entity2629 @entity810 @entity1011 @entity791 @entity204 @entity130 @entity454
Between January 1982 and December 1986, among the 750 @entity1 with the @entity791 ( @entity791 ) who were treated at two adjacent hospitals in New York City, 78 (10.4 percent) needed evaluation for @entity8 . Reversible @entity810 due to @entity130 , @entity63 , or both was present in 23 @entity1 (30 percent) (Group I). The remaining 55 (70 percent) had massive @entity644 , @entity2629 , or both ( @entity791 -associated @entity8 ; Group II), and irreversible @entity5507 developed in 43. In an additional 18 @entity1 , all of whom had a history of intravenous narcotic drug use, @entity791 was diagnosed after the initiation of maintenance hemodialysis for @entity177 (Group III). Survival for more than six months after the onset of @entity5507 occurred in only two subjects in Group II; all @entity1 in Group III died within three months of the diagnosis of @entity791 . @entity204 in the @entity1 in Groups II and III followed a syndrome of "failure to thrive" characterized by inanition unresponsive to intensive nutritional support and hemodialysis. In contrast, 8 of 17 @entity1 with @entity810 (Group I) and a serum @entity1011 concentration above 6 mg per deciliter regained renal function (serum @entity1011 level, less than 2.0 mg per deciliter). Four of the seven lived for 10 to 24 months, whereas the other four died of @entity295 within a month. Our observations suggest that maintenance hemodialysis is not effective in prolonging life either in @entity1 with @entity791 -associated @entity8 and @entity5507 or in @entity1 with @entity454 in whom @entity791 develops during the course of maintenance dialysis. Hemodialysis may be useful in the management of potentially reversible @entity810 in @entity1 with @entity791 .
